---
schema-version: v1.2.8
id: ISO10993-16-2010
title:
- content: Biological evaluation of medical devices
  language:
  - en
  script:
  - Latn
  format: text/plain
  type: title-main
- content: 'Part 16: Toxicokinetic study design for degradation products and leachables'
  language:
  - en
  script:
  - Latn
  format: text/plain
  type: title-part
- content: 'Biological evaluation of medical devices - Part 16: Toxicokinetic study
    design for degradation products and leachables'
  language:
  - en
  script:
  - Latn
  format: text/plain
  type: main
- content: Évaluation biologique des dispositifs médicaux
  language:
  - fr
  script:
  - Latn
  format: text/plain
  type: title-main
- content: 'Partie 16: Conception des études toxicocinétiques des produits de dégradation
    et des substances relargables'
  language:
  - fr
  script:
  - Latn
  format: text/plain
  type: title-part
- content: 'Évaluation biologique des dispositifs médicaux - Partie 16: Conception
    des études toxicocinétiques des produits de dégradation et des substances relargables'
  language:
  - fr
  script:
  - Latn
  format: text/plain
  type: main
link:
- content: https://www.iso.org/standard/45367.html
  type: src
- content: https://www.iso.org/contents/data/standard/04/53/45367.detail.rss
  type: rss
type: standard
docid:
- id: ISO 10993-16:2010
  type: ISO
  primary: true
- id: ISO 10993-16:2010(E)
  type: iso-reference
- id: urn:iso:std:iso:10993:-16:stage-95.99
  type: URN
docnumber: '10993'
date:
- type: published
  value: 2010-02
contributor:
- organization:
    name:
    - content: International Organization for Standardization
    abbreviation:
      content: ISO
    url: www.iso.org
  role:
  - type: publisher
edition:
  content: '2'
revdate: 2010-02
language:
- en
- fr
script:
- Latn
abstract:
- content: ISO 10993-16:2010 gives principles on how toxicokinetic studies relevant
    to medical devices should be designed and performed. Annex A describes the considerations
    for inclusion of toxicokinetic studies in the biological evaluation of medical
    devices.
  language:
  - en
  script:
  - Latn
  format: text/plain
- content: L'ISO 10993-16:2010 énonce les principes de conception et de mise en œuvre
    des études toxicocinétiques relatives aux dispositifs médicaux. L'Annexe A décrit
    les considérations relatives à l'inclusion d'études toxicocinétiques dans l'évaluation
    biologique des dispositifs médicaux.
  language:
  - fr
  script:
  - Latn
  format: text/plain
docstatus:
  stage:
    value: '95'
  substage:
    value: '99'
copyright:
- owner:
  - name:
    - content: ''
  from: '2010'
relation:
- type: obsoletes
  bibitem:
    id: ISO10993-16-1997
    type: standard
    docid:
    - id: ISO 10993-16:1997
      type: ISO
      primary: true
    formattedref:
      content: ISO 10993-16:1997
      format: text/plain
- type: updates
  bibitem:
    id: ISO10993-16-2017
    type: standard
    docid:
    - id: ISO 10993-16:2017
      type: ISO
      primary: true
    date:
    - type: circulated
      value: '2017-05-16'
    formattedref:
      content: ISO 10993-16:2017
      format: text/plain
place:
- Geneva
doctype:
  type: international-standard
editorialgroup:
  technical_committee:
  - name: Biological and clinical evaluation of medical devices
    number: 194
    type: TC
    identifier: ISO/TC 194
ics:
- code: 11.100.20
  text: Biological evaluation of medical devices
structuredidentifier:
  project_number: ISO 10993
  part: '16'
  type: ISO
ext:
  schema-version: v1.0.0
